Applied Economic Evaluation

From its inception in 2005, the Institute and its members have been involved in applied health economic evaluations, ranging from cost effectiveness analyses (CEAs) and budget impact projections, health care utilization and costing studies, to complex willingness-to-pay analyses. Therapeutic areas covered include mental health care (in particular, attention-deficit hyperactivity disorder, ADHD), cancer, rare diseases, type 2 diabetes mellitus; the technologies covered range from biopharmaceutical products, psychotherapeutic interventions, advanced therapy medicinal products, complex organizational designs, to diagnostics and medical devices.

More detailed information will follow soon, including projects on the following topics:

• Cost Effectiveness Analyses
• Budget Impact Analyses
• Diagnostics & Medical Devices